{"id":"W2776736524","doi":"10.1016/s1470-2045(17)30912-9","title":"Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; BC Cancer Agency; University of British Columbia","keywords":"Brentuximab vedotin; Medicine; Bendamustine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Regimen; Lymphoma; Chemotherapy; Chemotherapy regimen; Refractory (planetary science); Surgery; CD30; Rituximab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001675136,0.001592636,0.002372834,0.0003349533,0.00030796,0.001113732,0.0008935844,0.001070658,0.00288453],"category_scores_gemma":[0.001000788,0.0004998644,0.001426752,0.0003917033,0.001087682,0.001430815,0.000488129,0.003763929,0.0007200863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005418,"about_ca_system_score_gemma":0.0008079212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008614464,"about_ca_topic_score_gemma":0.002255193,"domain_scores_codex":[0.9994729,0.0002465311,0.00001891712,0.0000956135,0.00003645667,0.0001295567],"domain_scores_gemma":[0.9994449,0.0001120419,0.00009781303,0.00004607046,0.00002479749,0.0002744111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9208043,0.005897897,0.001438381,0.0009851408,0.001968749,0.0001072585,0.0001601499,0.002164229,0.00762769,0.0003366504,0.00290704,0.0556026],"study_design_scores_gemma":[0.9203438,0.07137642,0.004129949,0.00006024839,0.0005560597,0.0001286162,0.00005142091,0.0007095345,0.0006512498,0.0003744368,0.001590355,0.00002798291],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862596,0.008106565,0.0005725109,0.0008403604,0.0004265001,0.0006707555,0.00078173,0.0001051422,0.002236877],"genre_scores_gemma":[0.9896849,0.003556632,0.001162681,0.001165838,0.00019569,0.0006668218,0.001406442,0.00003235612,0.002128596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00288453,"threshold_uncertainty_score":0.009649754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1513362077320565,"score_gpt":0.4312362036939666,"score_spread":0.2798999959619101,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}